India · Delayed Price · Currency is INR Zydus Lifesciences Statistics
Total Valuation
NSE:ZYDUSLIFE has a market cap or net worth of INR 1.19 trillion. The enterprise value is 1.29 trillion.
| Market Cap | 1.19T |
| Enterprise Value | 1.29T |
Important Dates
The next confirmed earnings date is Wednesday, November 4, 2026.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | Jul 24, 2026 |
Share Statistics
NSE:ZYDUSLIFE has 997.50 million shares outstanding. The number of shares has decreased by -0.25% in one year.
| Current Share Class | 997.50M |
| Shares Outstanding | 997.50M |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 75.65% |
| Owned by Institutions (%) | 15.42% |
| Float | 241.13M |
Valuation Ratios
The trailing PE ratio is 28.40 and the forward PE ratio is 26.34. NSE:ZYDUSLIFE's PEG ratio is 9.25.
| PE Ratio | 28.40 |
| Forward PE | 26.34 |
| PS Ratio | 3.90 |
| PB Ratio | 3.91 |
| P/TBV Ratio | 12.61 |
| P/FCF Ratio | 438.13 |
| P/OCF Ratio | 29.20 |
| PEG Ratio | 9.25 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.70, with an EV/FCF ratio of 475.15.
| EV / Earnings | 30.61 |
| EV / Sales | 4.23 |
| EV / EBITDA | 17.70 |
| EV / EBIT | 24.15 |
| EV / FCF | 475.15 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.02 |
| Quick Ratio | 0.53 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 1.96 |
| Debt / FCF | 51.63 |
| Interest Coverage | 9.96 |
Financial Efficiency
Return on equity (ROE) is 14.72% and return on invested capital (ROIC) is 10.29%.
| Return on Equity (ROE) | 14.72% |
| Return on Assets (ROA) | 6.34% |
| Return on Invested Capital (ROIC) | 10.29% |
| Return on Capital Employed (ROCE) | 13.83% |
| Weighted Average Cost of Capital (WACC) | 5.62% |
| Revenue Per Employee | 10.12M |
| Profits Per Employee | 1.40M |
| Employee Count | 29,980 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.45 |
Taxes
In the past 12 months, NSE:ZYDUSLIFE has paid 14.00 billion in taxes.
| Income Tax | 14.00B |
| Effective Tax Rate | 24.56% |
Stock Price Statistics
The stock price has increased by +21.11% in the last 52 weeks. The beta is 0.31, so NSE:ZYDUSLIFE's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +21.11% |
| 50-Day Moving Average | 1,154.26 |
| 200-Day Moving Average | 1,037.60 |
| Relative Strength Index (RSI) | 54.42 |
| Average Volume (20 Days) | 1,548,036 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ZYDUSLIFE had revenue of INR 303.50 billion and earned 41.98 billion in profits. Earnings per share was 41.83.
| Revenue | 303.50B |
| Gross Profit | 219.12B |
| Operating Income | 51.98B |
| Pretax Income | 57.00B |
| Net Income | 41.98B |
| EBITDA | 71.39B |
| EBIT | 51.98B |
| Earnings Per Share (EPS) | 41.83 |
Balance Sheet
The company has 52.16 billion in cash and 139.66 billion in debt, with a net cash position of -87.51 billion or -87.72 per share.
| Cash & Cash Equivalents | 52.16B |
| Total Debt | 139.66B |
| Net Cash | -87.51B |
| Net Cash Per Share | -87.72 |
| Equity (Book Value) | 303.23B |
| Book Value Per Share | 278.92 |
| Working Capital | 4.10B |
Cash Flow
In the last 12 months, operating cash flow was 40.58 billion and capital expenditures -37.88 billion, giving a free cash flow of 2.71 billion.
| Operating Cash Flow | 40.58B |
| Capital Expenditures | -37.88B |
| Depreciation & Amortization | 19.41B |
| Net Borrowing | 30.52B |
| Free Cash Flow | 2.71B |
| FCF Per Share | 2.71 |
Margins
Gross margin is 72.20%, with operating and profit margins of 17.13% and 13.83%.
| Gross Margin | 72.20% |
| Operating Margin | 17.13% |
| Pretax Margin | 18.78% |
| Profit Margin | 13.83% |
| EBITDA Margin | 23.52% |
| EBIT Margin | 17.13% |
| FCF Margin | 0.89% |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.08%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 0.08% |
| Dividend Growth (YoY) | -90.91% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 2.39% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.25% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 3.52% |
| FCF Yield | 0.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:ZYDUSLIFE is 1,220.98, which is 2.77% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,220.98 |
| Price Target Difference | 2.77% |
| Analyst Consensus | Hold |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 12.11% |
| EPS Growth Forecast (3Y) | 0.37% |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
| Last Split Date | Oct 6, 2015 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |